Generating Evidence Toward Health and Well-Being
The ISPOR Europe 2024 conference, themed “Generating Evidence Toward Health and Well-Being,” was held 17 - 20 November in Barcelona, Spain. The conference program centered on the importance of scientific evidence in understanding and improving the health and well-being of people across the globe. Sessions focused on the science, practice, and policies of healthcare value assessment and promoted a broader view of health economics and outcomes research (HEOR) that considers the physical, mental, and social health aspects of innovation.
The conference also delved into:
- Joint Clinical Assessments
 - Real-World Data
 - Expanded Definition of Healthcare Value
 - Patient-Centered Research
 - Digital Transformation of Health
 - European Regulatory and Policy Developments
 
ISPOR Real-World Evidence Summit 2024—17 November 
A co-located event at ISPOR Europe 2024
The ISPOR Real-World Evidence Summit 2024 was held on 17 November and was a colocated event with ISPOR Europe 2024.
Speakers
                                 Director | National Institute for Value and Technologies in Healthcare (NIH) 
                            
                        
                                 Senior Policy Analyst, Health Division | Organization for Economic Co-operation and Development (OECD) 
                            
                        
                                 Section Head, Health Data Sciences and Professor | Botnar Research Centre, University of Oxford and Erasmus MC 
                            
                        
                                 Associate Professor & Director | Harvard Medical School & The Institute for Technology Assessment at Massachusetts General Hospital 
                            
                        
                                 Head at HTA Strategy and External Engagement | National Centre for Pharmacoeconomics, Dublin, Ireland & Discipline of Pharmacology and Therapeutics, Trinity College Dublin 
                            
                        
                                 Advisor, Co-Chair JCA Subgroup under the HTA Coordination Group, Research, Development & International Affairs | National Health Care Institute 
                            
                        
                                 Head of the Real World Evidence (TDA-RWE), Data Analytics and Methods Task Force (TDA) | European Medicines Agency 
                            
                        
                                 Professor of Medicine and Epidemiology & Chief of the Division of Pharmacoepidemiology, Department of Medicine | Harvard Medical School & Brigham and Women’s Hospital 
                            
                        







-1.jpg?sfvrsn=622150aa_2)

.jpg?sfvrsn=dfcea19_2)








